Genetic instabilities in human cancers
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Whether and how human tumours are genetically unstable has been debated for decades. There is now evidence that most cancers may indeed be genetically unstable, but that the instability exists at two distinct levels. In a small subset of tumours, the instability is observed at the nucleotide level and results in base substitutions or deletions or insertions of a few nucleotides. In most other cancers, the instability is observed at the chromosome level, resulting in losses and gains of whole chromosomes or large portions thereof. Recognition and comparison of these instabilities are leading to new insights into tumour pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic defects such as DNA mismatch repair deficiencies (dMMR) and microsatellite instability (MSI) predispose tumor cells to the accumulation of somatic mutations and are associated with increased TMB (Lengauer et al., 1998) and increased susceptibility to ICB (Le et al., 2017).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Lengauer et al., 1998
Citations
Cites
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G., & Schaid, D. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,130
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., & Kolodner, R. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,873
Clues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J.-P., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,710
Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,708
Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomäki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90330-s · Cited by 2,276
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,270
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., & Perucho, M. (1988) · Cell · doi:10.1016/0092-8674(88)90571-5 · Cited by 2,114
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,039
Cited by
Items 601–700 of 1,009
Wang, H., Hu, X., Ding, X., Dou, Z., Yang, Z., Shaw, A. W., Teng, M., Cleveland, D. W., Goldberg, M. L., Niu, L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407588200 · Cited by 126
The DNA Damage Signaling Pathway Connects Oncogenic Stress to Cellular Senescence
Mallette, F. A., & Ferbeyre, G. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4516 · Cited by 125
Malignant complications of coeliac disease
Brousse, N., & Meijer, J. W. R. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.02.002 · Cited by 125
Expression of activation‐induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis
Kou, T., Marusawa, H., Kinoshita, K., Endo, Y., Okazaki, I., Ueda, Y., Kodama, Y., Haga, H., Ikai, I., & Chiba, T. (2006) · International Journal of Cancer · doi:10.1002/ijc.22292 · Cited by 129
“Carcinogenesis is a multistep process that involves the accumulation of mutations in genes that govern cell proliferation, regeneration and apoptosis.(1,2) Although the molecular events directly linked to the development and progression of human hepatocellular carcinoma (HCC) are not well understood, it is believed th…”
BackgroundVardy, L. A., & Toda, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6098 · Cited by 128
Jass, J. R., Walsh, M. D., Barker, M., Simms, L. A., Young, J. P., & Leggett, B. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00041-2 · Cited by 142
“Chromosomal instability is regarded as a prerequisite for the stepwise development of the ‘suppressor’ pathway in which mutation of APC is the initiating event [6].”
BackgroundClinical Utility of Contemporary Molecular Cytogenetics
Bejjani, B. A., & Shaffer, L. G. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164207 · Cited by 133
Molecular genetics of prostate cancer
Elo, J. P., & Visakorpi, T. (2001) · Annals of Medicine · doi:10.3109/07853890109002068 · Cited by 126
Autophagy in tumorigenesis and cancer therapy: Dr. Jekyll or Mr. Hyde?
Zhou, S., Zhao, L., Kuang, M., Zhang, B., Liang, Z., Yi, T., Wei, Y., & Zhao, X. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.017 · Cited by 136
“While DNA damage gives rise to the process of tumorigenesis and even results in a variety of mutations indispensable for tumorigenesis, overwhelming DNA damage can cause dysfunction of tumor-suppressing housekeeping genes [51,52].”
BackgroundA mathematical framework to determine the temporal sequence of somatic genetic events in cancer
Attolini, C. S., Cheng, Y.-K., Beroukhim, R., Getz, G. A., Abdel-Wahab, O. I., Levine, R. L., Mellinghoff, I. K., & Michor, F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009117107 · Cited by 140
“Other parameters, such as cellular population size, mutation rate and influx rate, are estimated from experimental results (8, 9) and tested for robustness over several orders of magnitude (see SI Text).”
MethodChromosomal Instability in Tumor Initiation and Development
Bach, D., Zhang, W., & Sood, A. K. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3235 · Cited by 140
“It has been suggested that these chromosomal aberrations are highly associated with human cancers because the aberrations allow cells to rapidly acquire genetic changes (26) with diverse mechanisms; the causative functions of these aberrations in cancer progression have been reviewed in detail in previous reports (27,…”
The occurrence and significance of V gene mutations in B cell—Derived human malignancy
Stevenson, F. K., Sahota, S. S., Ottensmeier, C. H. H., Zhu, D., Forconi, F., & Hamblin, T. J. (2001) · Advances in cancer research · doi:10.1016/s0065-230x(01)83004-9 · Cited by 136
DNA replication timing, genome stability and cancer
Donley, N., & Thayer, M. J. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.01.001 · Cited by 156
“The first is chromosome instability (CIN), which is characterized by an increase in the rate at which cells gain or lose entire chromosomes [132].”
BackgroundDNA copy number amplification profiling of human neoplasms
Myllykangas, S., Himberg, J., Böhling, T., Nagy, B., Hollmén, J., & Knuutila, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209717 · Cited by 124
“In contrast to the definition of amplification, DNA copy number increase in larger chromosomal areas or intact chromosomes, owing to translocations or aneuploidy, is defined as a gain (Lengauer et al., 1998).”
BackgroundPoly(ADP-ribose) polymerase inhibitors in cancer treatment: A clinical perspective
Sandhu, S. K., Yap, T. A., & Bono, J. S. D. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.021 · Cited by 130
“Overall, it is increasingly evident that genomic instability due to defects in DNA repair pathways is a common characteristic of many tumours.(70) This suggests that similar synthetic lethal strategies targeting DNA repair pathways may be broadly applicable to multiple tumour types.”
BackgroundWatanabe, T., Kobunai, T., Yamamoto, Y., Matsuda, K., Ishihara, S., Nozawa, K., Yamada, H., Hayama, T., Inoue, E., Tamura, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.6490 · Cited by 123
Kumar, G., Mittal, S., Sak, K., & Tuli, H. S. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.022 · Cited by 128
Chromosomal Variation in Mammalian Neuronal Cells: Known Facts and Attractive Hypotheses
Iourov, I. Y., Vorsanova, S. G., & Yurov, Y. B. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)49003-3 · Cited by 128
Expression and genomic profiling of colorectal cancer
Cardoso, J., Boer, J. M., Morreau, H. M., & Fodde, R. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.004 · Cited by 141
p53 sends nucleotides to repair DNA
Lozano, G., & Elledge, S. J. (2000) · Nature · doi:10.1038/35003670 · Cited by 123
Mutations in the mitotic check point gene, MAD1L1, in human cancers
Tsukasaki, K., Miller, C. W., Greenspun, E., Eshaghian, S., Kawabata, H., Fujimoto, T., Tomonaga, M., Sawyers, C. L., SAID, J. W., & Koeffler, H. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204421 · Cited by 122
“Keywords: MAD1L1; mitotic checkpoint; chromosomal instability; prostate cancer; breast cancer; adult Tcell leukemia/lymphoma Genetic instability in cancers exists in two distinct arenas, the nucleotide and chromosomal level (Lengauer et al., 1998).”
BackgroundAnticancer agent CHS-828 inhibits cellular synthesis of NAD
Olesen, U. H., Christensen, M. K., Björkling, F., Jäättelä, M., Jensen, P. B., Sehested, M., & Nielsen, S. J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.019 · Cited by 126
Thorstensen, L., Lind, G. E., Løvig, T., Diep, C. B., Meling, G. I., Rognum, T. O., & Lothe, R. A. (2005) · Neoplasia · doi:10.1593/neo.04448 · Cited by 148
“The CIN tumors are typically microsatellite-stable (MSS), aneuploid, and located in the distal colon or in the rectum [21].”
BackgroundInfluentialWang, L., Tsutsumi, S., Kawaguchi, T., Nagasaki, K., Tatsuno, K., Yamamoto, S., Sang, F., Sonoda, K., Sugawara, M., Saiura, A., et al. (2012) · Genome Research · doi:10.1101/gr.123109.111 · Cited by 122
“Genomic instability is a characteristic feature of almost all human cancers (Lengauer et al. 1998; Negrini et al. 2010).”
BackgroundProgressive methylation during the serrated neoplasia pathway of the colorectum
Dong, S. M., Lee, E. J., Jeon, E. S., Park, C. K., & Kim, K. (2004) · Modern Pathology · doi:10.1038/modpathol.3800261 · Cited by 121
Chui, M. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27745 · Cited by 134
Cea, M., Cagnetta, A., Adamia, S., Acharya, C., Tai, Y.-T., Fulciniti, M., Ohguchi, H., Munshi, A., Acharya, P., Bhasin, M. K., et al. (2016) · Blood · doi:10.1182/blood-2015-06-649970 · Cited by 121
Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis.
Bergoglio, V., Pillaire, M., Lacroix‐Triki, M., Raynaud‐Messina, B., Canitrot, Y., Bieth, A., Garès, M., Wright, M., Delsol, G., Loeb, L. A., et al. (2002) · PubMed · Cited by 121
Tanaka, H., Tapscott, S. J., Trask, B. J., & Yao, M.-C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132275999 · Cited by 121
Genetic knockouts and knockins in human somatic cells
Rago, C., Vogelstein, B., & Bunz, F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.408 · Cited by 130
“Furthermore, cancer cells are inherently genetically unstable and therefore acquire alterations during extended in vitro propagatio”
BackgroundKim, Y. H., Kakar, S., Cun, L., Deng, G., & Kim, Y. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.23840 · Cited by 130
“003 0 (0) 3 (21) ns 0 (0) 3 (14) ns 0 (0) 0 (0) ns Low 7 (33) 16 (59) ns 9 (50) 6 (43) ns 2 (25) 12 (55) ns 12 (75) 11 (69) ns High 14 (67) 2 (8) <0.”
Gaymes, T. J., Mufti, G. J., & Rassool, F. V. (2002) · PubMed · Cited by 137
Kawauchi, S., Kusuda, T., Liu, X.-P., Suehiro, Y., Kaku, T., Mikami, Y., Takeshita, M., Nakao, M., Chochi, Y., & Sasaki, K. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181883722 · Cited by 120
“From studies of colorectal and other cancers, cancers with genetic instability have been classified into 2 categories, that is, the chromosomal instability (CIN) phenotype and the MSI phenotype.(17,18) The majority of cancers belongs to the CIN phenotype and is characterized by abnormal chromosome number.”
BackgroundDevelopment of novel therapeutic strategies that target HIF-1
Semenza, G. L. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.2.267 · Cited by 120
“In cancer cells, the transcription of many tumour suppressor genes is turned off through epigenetic regulation of histone acetylation and DNA methylation [115].”
BackgroundInfluentialDuensing, S. M., & Münger, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205709 · Cited by 141
“Human papillomaviruses and genomic instability Genomic instability is frequently observed in HPVassociated cervical cancer as well as in many other human malignancies (reviewed in Lengauer et al., 1998).”
BackgroundLiu, L., De, S., & Michor, F. (2013) · Nature Communications · doi:10.1038/ncomms2502 · Cited by 119
Chen, M.-J., Lin, Y.-T., Lieberman, H. B., Chen, G., & Lee, E. Y.-H. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008871200 · Cited by 119
Ubiquitylation-dependent localization of PLK1 in mitosis
Beck, J., Maerki, S., Posch, M., Metzger, T., Persaud, A., Scheel, H., Hofmann, K., Rotin, D., Pedrioli, P., Swedlow, J. R., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2695 · Cited by 117
Romero, F., Multon, M. C., Ramos-Morales, F., Domínguez, A., Bernal, J. A., Pintor-Toro, J. A., & Tortolero, M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.6.1300 · Cited by 140
“The finding that a vertebrate securin has tumorigenic activity is somewhat anticipated because chromosome missegregation has been predicted to be a major source of genetic instability, with profound consequences for cancer (13).”
VanderVeen, L. A., Hashim, M. F., Shyr, Y., & Marnett, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2332176100 · Cited by 118
McCammon, M. T., Epstein, C. B., Przybyla-Zawislak, B., McAlister-Henn, L., & Butow, R. A. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-07-0422 · Cited by 119
“Both types of mutation accumulation occur in cancer cell lines (Lengauer et al., 1998).”
BackgroundSpontaneous DNA Damage, Genome Instability, and Cancer—When DNA Replication Escapes Control
Schär, P. (2001) · Cell · doi:10.1016/s0092-8674(01)00220-3 · Cited by 136
Lo, A. W. I., Sprung, C. N., Fouladi, B., Pedram, M., Sabatier, L., Ricoul, M., Reynolds, G. E., & Murnane, J. P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4836-4850.2002 · Cited by 118
“The status of cell cycle checkpoints, which are commonly defective in cancer cells, could prevent B/F/B cycles through the elimination of cells containing dicentric or broken chromosomes (37).”
BackgroundRajesh, C., Baker, D. K., Pierce, A. J., & Pittman, D. L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq738 · Cited by 132
“Defective DNA damage response and repair mechanisms are underlying causes for the increased genetic instability and chromosomal translocations associated with the evolution of cancer (1,2).”
BackgroundSalisbury, J. (1999) · Biology of the Cell · doi:10.1016/s0248-4900(99)80086-0 · Cited by 118
Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell–macrophage lineage
Egeler, R. M., van Halteren, A. G. S., Hogendoorn, P. C. W., Laman, J. D., & Leenen, P. J. M. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00883.x · Cited by 121
“Could LCH be the result of a series of genetic and cellular events that may govern the formation of most types of human cancers? It is known that increased mutability is essential for the development of many types of human cancers (66).”
BackgroundStem-like Cancer Cells Are Inducible by Increasing Genomic Instability in Cancer Cells
Liang, Y., Zhong, Z., Huang, Y., Deng, W., Cao, J., Tsao, G., Liu, Q., Pei, D., Kang, T., & Zeng, Y.-X. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.048397 · Cited by 117
A Review of the Genomics of Gastric Cancer
Hamilton, J. P., & Meltzer, S. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.01.019 · Cited by 127
Selective advantage of trisomic human cells cultured in non-standard conditions
Rutledge, S. D., Douglas, T. A., Nicholson, J. M., Vila-Casadesús, M., Kantzler, C. L., Wangsa, D., Barroso‐Vilares, M., Kale, S. D., Logarinho, E., & Cimini, D. (2016) · Scientific Reports · doi:10.1038/srep22828 · Cited by 133
“However, this may be due to the fact that a combination of the high rates of mutation displayed by non-CIN CRC cells 54 and the increase in CIN triggered by aneuploidy may not be tolerated and may cause cell death rather than a proliferative advantage.”
The phosphorylation status of PAS‐B distinguishes HIF‐1α from HIF‐2α in NBS1 repression
To, K. K. W., Sedelnikova, O. A., Samons, M., Bonner, W. M., & Huang, E. L. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601369 · Cited by 145
“Genetic instability is a hallmark of most human cancers, arising from changes at the nucleotide and the chromosomal levels (Lengauer et al, 1998).”
BackgroundTsuchiya, N., Ochiai, M., Nakashima, K., Ubagai, T., Sügimura, T., & Nakagama, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2707 · Cited by 128
CENP‐C is necessary but not sufficient to induce formation of a functional centromere
Fukagawa, T., Pendon, C., Morris, J., & Brown, W. (1999) · The EMBO Journal · doi:10.1093/emboj/18.15.4196 · Cited by 120
“Although errors of chromosome segregation are an important cause of genetic diseases including cancer (Lengauer et al., 1998), the problem of how centromeres interact with the microtubules of the spindle at cell division is not understood.”
BackgroundYang, J., Chen, Z., Liu, Y., Hickey, R. J., & Malkas, L. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0603 · Cited by 117
“In addition to large chromosomal changes involving thousands of bp, another form of genetic instability results in an increased mutation rate at the nucleotide level due to a perturbation in nucleotide synthesis or in cellular processes such as DNA repair and replication (1).”
BackgroundHuman intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer
Candela, M., Guidotti, M., Fabbri, A., Brigidi, P., Franceschi, C., & Fiorentini, C. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.501760 · Cited by 116
Alteration of Gene Expression by Chromosome Loss in the Postnatal Mouse Brain
Kaushal, D., Contos, J. J. A., Treuner, K., Yang, A. H., Kingsbury, M. A., Rehen, S. K., McConnell, M. J., Okabe, M., Barlow, C., & Chun, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05599.2003 · Cited by 116
“Given the preponderance of chromosome loss among aneuploid cells, many SVZ and OB cells likely harbor multiple losses of heterozygosity (Lengauer et al., 1998; Serra et al., 2001; Thiagalingam et al., 2002).”
BackgroundTaylor, S. T., Hickman, J. A., & Dive, C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.1.18 · Cited by 116
ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice
Casimiro, M. C., Crosariol, M., Loro, E., Ertel, A., Yu, Z., Dampier, W., Saria, E. A., Papanikolaou, A., Stanek, T. J., Li, Z., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60256 · Cited by 115
The BLM dissolvasome in DNA replication and repair
Manthei, K. A., & Keck, J. L. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1325-1 · Cited by 130
CHK1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair pathway deficient tumors
Chen, C. C., Kennedy, R. D., Sidi, S., Look, A. T., & D'Andrea, A. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-24 · Cited by 115
“Background Human cancers exhibit genomic instability and heightened drug sensitivity due to underlying defects in DNA repair or cell cycle regulation [1-3].”
BackgroundReddy, B. S. (2004) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20026 · Cited by 113
Phenotype-Based Identification of Mouse Chromosome Instability Mutants
Shima, N., Hartford, S. A., Duffy, T., Wilson, L. A., Schimenti, K. J., & Schimenti, J. C. (2003) · Genetics · doi:10.1093/genetics/163.3.1031 · Cited by 115
Role of homologous recombination in carcinogenesis
Bishop, A. J. R., & Schiestl, R. H. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00010-8 · Cited by 131
Important molecular genetic markers of colorectal cancer
Kudryavtseva, A. V., Lipatova, A. V., Zaretsky, A. R., Moskalev, A. A., Fedorova, M. S., Rasskazova, A. S., Shibukhova, G. A., Snezhkina, A. V., Kaprin, A. D., Alekseev, B. Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9796 · Cited by 114
“In CIN tumors, as a rule, there is a loss of 25-30% alleles [7].”
BackgroundSimian virus 40 infection in humans and association with human diseases: results and hypotheses
Barbanti‐Brodano, G., Sabbioni, S., Martini, F., Negrini, M., Corallini, A., & Tognon, M. G. (2004) · Virology · doi:10.1016/j.virol.2003.09.004 · Cited by 123
The kinetochore and cancer: what's the connection?
Yuen, K. W., Montpetit, B., & Hieter, P. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.012 · Cited by 114
Targeting Aurora-2 kinase in cancer.
Warner, S. L., Bearss, D. J., Han, H., & Hoff, D. D. V. (2003) · PubMed · Cited by 114
Mutation Detection by Real-Time PCR: A Simple, Robust and Highly Selective Method
Morlan, J., Baker, J., & Sinicropi, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004584 · Cited by 113
“[2].”
Mi, L., Gan, N., Cheema, A., Dakshanamurthy, S., Wang, X., Yang, D. C. H., & Chung, F.-L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901789200 · Cited by 113
Schoch, C., Haferlach, T., Bursch, S., Gerstner, D., Schnittger, S., Dugas, M., Kern, W., Löffler, H., & Hiddemann, W. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10088 · Cited by 118
“Several genes involved in the DNAdamage checkpoints have been implicated in human tumorigenesis, including ATM, BRCA1, BRCA2, RAD51, and TP53 (Lengauer et al., 1998).”
BackgroundSomatic gene mutation and human disease other than cancer
Erickson, R. P. (2003) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(03)00010-3 · Cited by 124
“[3] C.”
BackgroundMasuda, A., Maeno, K., Nakagawa, T., Saito, H., & Takahashi, T. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63470-0 · Cited by 126
“This checkpoint thus prevents abnormal chromosome segregation because of the lack of bipolar attachment of kinetochores to mitotic spindles, and its dysfunction in cancer cells is thought to play a role in the development of chromosome instability.(5,6) Anti-microtubule agents including nocodazole, vinorelbine, and pa…”
BackgroundTong, W., Cortes, U., Hande, M. P., Ohgaki, H., Cavalli, L. R., Lansdorp, P. M., Haddad, B. R., & Wang, Z. (2002) · PubMed · Cited by 126
PICH: A DNA Translocase Specially Adapted for Processing Anaphase Bridge DNA
Biebricher, A. S., Hirano, S., Enzlin, J. H., Wiechens, N., Streicher, W. W., Huttner, D., Wang, L. H.-C., Nigg, E. A., Owen‐Hughes, T., Liu, Y., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.016 · Cited by 112
“A failure to efficiently execute sister chromatid disjunction can lead to the formation of anaphase DNA bridges and micronuclei (Lengauer et al., 1998).”
BackgroundProgress in refining the clinical management of cancer of unknown primary in the molecular era
Rassy, E., & Pavlidis, N. A. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0359-1 · Cited by 128
ATR functions as a gene dosage‐dependent tumor suppressor on a mismatch repair‐deficient background
Fang, Y., Tsao, C., Goodman, B. K., Furumai, R., Tirado, C. A., Abraham, R. T., & Wang, X.-F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600315 · Cited by 122
“This cell line is MMR defective due to the expression of markedly reduced levels of MLH1 (Papadopoulos et al, 1994), and has served as the host for previous gene-targeting efforts (Waldman et al, 1995; Brown et al, 1997; Bunz et al, 1998; Cahill et al, 1998; Lengauer et al, 1998).”
BackgroundRiethmüller, G., & Klein, C. A. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0386 · Cited by 112
Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
Ngan, V. K., Bellman, K., Panda, D., Hill, B. T., Jordan, M. A., & Wilson, L. (2000) · PubMed · Cited by 112
(2004) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2004-812996 · Cited by 112
Luk, C. K., Tsao, M., Bayani, J., Shepherd, F. A., & Squire, J. A. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00363-0 · Cited by 112
Molecular Biology of Barrett’s Adenocarcinoma
Wijnhoven, B. P. L., Tilanus, H. W., & Dinjens, W. N. M. (2001) · Annals of Surgery · doi:10.1097/00000658-200103000-00005 · Cited by 113
“The genomic instability occurs in two different forms, one characterized by microsatellite instability (MSI) and the other by chromosomal instability.(12) The targets of the genomic instability are four classes of genes: 1.”
Jane, J. A. (2005) · Neurosurgical FOCUS · doi:10.3171/foc.2005.19.5.5 · Cited by 113
RetractedDistinct Genetic Alterations in Colorectal Cancer
Ashktorab, H., Schäffer, A. A., Daremipouran, M., Smoot, D. T., Lee, E., & Brim, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008879 · Cited by 111
“In the remaining 47% of CRCs, chromosomal instability leads to gains and losses of large segments of chromosomes [8].”
BackgroundPersonalized Oncology Meets Immunology: The Path toward Precision Immunotherapy
Mandal, R., & Chan, T. A.-T. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0146 · Cited by 128
Tsukasaki, K., Krebs, J., Nagai, K., Tomonaga, M., Koeffler, H. P., Bartram, C. R., & Jauch, A. S. (2001) · Blood · doi:10.1182/blood.v97.12.3875 · Cited by 117
Genetic and epigenetic alterations as hallmarks of the intricate road to cancer
Macaluso, M., Paggi, M. G., & Giordano, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206955 · Cited by 127
“Indeed, cancer cells display almost constantly instability either in DNA sequence or in karyotype (Lengauer et al., 1998).”
BackgroundDevelopment of sarcomas in mice implanted with mesenchymal stem cells seeded onto bioscaffolds
Tasso, R., Augello, A., Carida’, M., Postiglione, F., Tibiletti, M. G., Bernasconi, B., Astigiano, S., Fais, F., Truini, M., Cancedda, R., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgn234 · Cited by 111
Kasai, T., Iwanaga, Y., Iha, H., & Jeang, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110295200 · Cited by 113
Centrosomal Kinases, HsAIRK1 and HsAIRK3, are Overexpressed in Primary Colorectal Cancers
Takahashi, T., Futamura, M., Yoshimi, N., Sano, J., Katada, M., Takagi, Y., Kimura, M., Yoshioka, T., Okano, Y., & Saji, S. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00878.x · Cited by 112
Thiagalingam, S., Foy, R. L., Cheng, K., Lee, H. J., Thiagalingam, A., & Ponte, J. F. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00012 · Cited by 124
Roschke, A. V., Stover, K., Tonon, G., Schäffer, A. A., & Kirsch, I. R. (2002) · Neoplasia · doi:10.1038/sj.neo.7900197 · Cited by 129
“The level of genomic instability cannot be determined by simply scoring the presence of genetic alterations in tumor cells because these alterations in different tumors may develop during different time intervals or with different rates of changes [5].”
BackgroundResultRegulation of Cell Survival and Death by Pyridine Nucleotides
Oka, S.-I., Hsu, C.-P., & Sadoshima, J. (2012) · Circulation Research · doi:10.1161/circresaha.111.247932 · Cited by 110
Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies
Jang, B., Kwon, H., Katila, P., Lee, S. J., & Lee, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.023 · Cited by 117
Order and Disorder: The Role of Extracellular Matrix in Epithelial Cancer
Radisky, D., Muschler, J., & Bissell, M. J. (2002) · Cancer Investigation · doi:10.1081/cnv-120000374 · Cited by 110
“Many investigations have characterized cancer as the consequence of genetic mutations that inactivate tumorsuppressor genes or activate oncogenes (107,108) and view cancer progression as the accumulation of genetic defects in overlapping pathways, each providing a progressive evolutionary advantages to the malignant p…”
BackgroundAn error catastrophe in cancer?
Solé, R. V., & Deisboeck, T. S. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2003.08.018 · Cited by 122
“Nonetheless, as Lengauer et al. (1998) already pointed out, genetic instability should denote a rate more than a state, hence the occurrence of a particular mutation in the genome of the cell over time.”
BackgroundWhat’s the Damage? The Impact of Pathogens on Pathways that Maintain Host Genome Integrity
Weitzman, M. D., & Weitzman, J. B. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.010 · Cited by 109
“The resolution and scale of genetic instability varies considerably, from subtle sequence changes involving base substitutions, deletions, or insertions of a few nucleotides to aneuploidy and gross alterations in chromosome structure (Lengauer et al., 1998).”
BackgroundAmplified Centrosomes in Breast Cancer: A Potential Indicator of Tumor Aggressiveness
D’Assoro, A. B., Barrett, S. L., Folk, C., Negron, V. C., Boeneman, K., Busby, R., Whitehead, C. M., Stivala, F., Lingle, W. L., & Salisbury, J. L. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1016550619925 · Cited by 130
“Breast cancer, like most other cancers, is characterized by complex and heterogeneous genetic alterations originating from genomic instability and aneuploidy [1].”
Centrosome abnormalities, genomic instability and carcinogenic progression
Duensing, S. M., & Münger, K. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00025-1 · Cited by 132
Rao, C. V., Yamada, H. Y., Yao, Y., & Dai, W. H. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp081 · Cited by 118
Recent advances in research on multistage tumorigenesis
Compagni, A., & Christofori, G. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1309 · Cited by 110
“In ue to uch 97). eous cy of deed, enes ion, x 999; thin our air by ions nized ular and however, it is possible that the sequence of events may be c for full transformation.”
Haplo-insufficiency? Let me count the ways: Figure 1.
Quon, K. C., & Berns, A. J. M. (2001) · Genes & Development · doi:10.1101/gad.949001 · Cited by 128
“Furthermore, nearly all human tumors show an enhanced mutation rate or chromosomal instability (Lengauer et al. 1998).”
Background
Metadata
- Authors
- Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1998-12
- Volume
- 396
- Issue
- 6712
- Pages
- 643-649
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1544851750
- Cited by
- 4,168
- References
- 98
- Citations by year
- 2026: 18 · 2025: 44 · 2024: 56 · 2023: 74 · 2022: 83 · 2021: 91 · 2020: 92 · 2019: 90 · 2018: 99 · 2017: 106 · 2016: 113 · 2015: 136 · 2014: 145 · 2013: 156 · 2012: 183
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- genomic instability, carcinogenesis, chromosomal instability, microsatellite instability, base substitutions, chromosomal deletion, chromosomal gains, cancer genetics
- MeSH terms
- Chromosome Aberrations, Gene Amplification, Humans, Neoplasms, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.